ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1
Authors:
- Chong HanCHChong Han
- Chunlin WangCWChunlin Wang
- Guohan HuGHGuohan Hu
- Chun LuoCLChun Luo
- Xiaoqiang GanXGXiaoqiang Gan
- Fenglin ZhangFZFenglin Zhang
- Yicheng LuYLYicheng Lu
- Xuehua DingXDXuehua Ding
Open Access
- 14 May 2012
- journal article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 49 (1) , 21-33
Abstract
ADAM10 is a metalloproteinase that regulates invasiveness in many tumors. Here, we found that ADAM10 expression correlates with the invasiveness of pituitary adenomas and contributes to invasion by cleaving L1 and CD44. In high-grade pituitary adenoma patients, ADAM10 expression levels were found to be elevated compared with low-grade pituitary adenomas. In a phorbol 12-myristate 13-acetate (PMA)-stimulated pituitary adenoma cell line, AtT-20 cells, we found that the cleavage of L1 was correspondingly enhanced with the increased interaction between Src and Shc. Increases in PMA-induced L1 cleavage and the phosphorylation of residue 418 of Src (418Src) were promoted by overexpression of ADAM10. Inversely, knockdown of Adam10 suppressed PMA-induced L1 cleavage and the phosphorylation of Src, which was blocked by the Src inhibitor PP2 and the MEK inhibitor PD98059. On the other hand, calcium flux activation in AtT-20 cells resulted in increased CD44 cleavage, with reduction of the interaction between calmodulin and ADAM10. The induction of enhanced CD44 cleavage by calcium flux activation was inhibited by knockdown of Adam10. In addition, Adam10 knockdown repressed AtT-20 cell migration, which was reversed by CD44EXT (CD44 ectodomain cleavage). Collectively, these data indicated that ADAM10 facilitated cell migration through modulation of CD44 and L1 cleavage.Keywords
This publication has 47 references indexed in Scilit:
- ADAM10 as a Therapeutic Target for Cancer and InflammationCurrent Pharmaceutical Design, 2009
- ADAMs, cell migration and cancerCancer and Metastasis Reviews, 2006
- Xenoestrogen-Induced ERK-1 and ERK-2 Activation via Multiple Membrane-Initiated Signaling PathwaysEnvironmental Health Perspectives, 2004
- ADAMs family members as amyloid precursor protein α‐secretasesJournal of Neuroscience Research, 2003
- L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasThe Lancet, 2003
- TACE is required for the activation of the EGFR by TGF‐α in tumorsThe EMBO Journal, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Distinct Roles of the Adaptor Protein Shc and Focal Adhesion Kinase in Integrin Signaling to ERKJournal of Biological Chemistry, 2000
- Neural cell recognition molecule L1: from cell biology to human hereditary brain malformationsCurrent Opinion in Neurobiology, 1998
- Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and NotchCell, 1997